Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037387
Filing Date
2016-08-15
Accepted
2016-08-15 10:19:25
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clsn20160630_10q.htm 10-Q 1145538
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 23520
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 23568
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8596
  Complete submission text file 0001437749-16-037387.txt   5296547

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS clsn-20160630.xml EX-101.INS 942487
6 EXHIBIT 101.SCH clsn-20160630.xsd EX-101.SCH 59809
7 EXHIBIT 101.CAL clsn-20160630_cal.xml EX-101.CAL 41603
8 EXHIBIT 101.DEF clsn-20160630_def.xml EX-101.DEF 390304
9 EXHIBIT 101.LAB clsn-20160630_lab.xml EX-101.LAB 342960
10 EXHIBIT 101.PRE clsn-20160630_pre.xml EX-101.PRE 414072
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 161830613
SIC: 2834 Pharmaceutical Preparations